CME Group Inc. $CME Shares Acquired by Keybank National Association OH

Keybank National Association OH raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 15.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 153,625 shares of the financial services provider’s stock after purchasing an additional 20,477 shares during the period. Keybank National Association OH’s holdings in CME Group were worth $41,508,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Howard Capital Management Inc. increased its holdings in shares of CME Group by 3.2% during the 3rd quarter. Howard Capital Management Inc. now owns 2,722 shares of the financial services provider’s stock worth $735,000 after buying an additional 84 shares during the last quarter. National Pension Service grew its position in CME Group by 1.1% during the third quarter. National Pension Service now owns 927,014 shares of the financial services provider’s stock valued at $250,470,000 after acquiring an additional 9,748 shares during the period. Winnow Wealth LLC increased its stake in CME Group by 43,330.0% during the third quarter. Winnow Wealth LLC now owns 4,343 shares of the financial services provider’s stock worth $1,177,000 after acquiring an additional 4,333 shares during the last quarter. Pittenger & Anderson Inc. increased its stake in CME Group by 1.5% during the third quarter. Pittenger & Anderson Inc. now owns 68,579 shares of the financial services provider’s stock worth $18,529,000 after acquiring an additional 1,025 shares during the last quarter. Finally, Cypress Capital Group raised its holdings in shares of CME Group by 2.2% in the 3rd quarter. Cypress Capital Group now owns 35,639 shares of the financial services provider’s stock worth $9,629,000 after purchasing an additional 777 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME stock opened at $289.06 on Friday. The firm has a fifty day simple moving average of $275.25 and a 200-day simple moving average of $272.35. The company has a market capitalization of $104.24 billion, a PE ratio of 28.01, a price-to-earnings-growth ratio of 3.26 and a beta of 0.27. CME Group Inc. has a twelve month low of $233.66 and a twelve month high of $291.76. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Friday, December 12th. CME Group’s payout ratio is presently 48.45%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CME shares. Rothschild & Co Redburn boosted their target price on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a report on Thursday, November 6th. Argus decreased their price objective on shares of CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a research report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. Finally, Jefferies Financial Group decreased their price target on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research report on Monday, January 12th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $292.18.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.